---
$id: https://graph.org.ai/products/commodity/51442439
$type: Product
source: UNSPSC
code: "51442439"
title: "Sodium iopodate"
class: "51442400"
classTitle: "Iodine-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium iopodate

**UNSPSC Code**: 51442439
**Class**: [Iodine-based radiopharmaceuticals, imaging agents, media, and tracers](Iodine-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diagnostic reagent with the molecular formula C12H12I3N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F316LLW9WW, chemically known as 2,4,6-triiodo-3-((dimethylaminomethylene)amino)hydrocinnamic acid but more generally known as ipodate sodium, which bears U.S. National Institutes of Health Compound Identifier 5241. European Medicines Agency schedules Sodium iopodate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12441MIG. The term SODIUM IOPODATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules ipodate sodium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium iopodate under HS 29252900 and SITC 51482. SMILES: CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.[Na+].

